What Has Driven the Growth of the Hospital-Acquired Infection Control Market in Recent Years?
The hospital-acquired infection control market has seen considerable growth due to a variety of factors.
• Over the past years, the market size of hospital-acquired infection control has been progressively increasing. The market, which is projected to rise from $34.59 billion in 2024 to $35.86 billion in 2025, will have a compound annual growth rate (CAGR) of 3.7%.
The historic growth of the market is linked to factors such as the rise of antibiotic resistance, heightened consciousness, strict regulations, global spread of infectious diseases, and patient safety initiatives.
What is the Forecasted Market Size and CAGR for the Hospital-Acquired Infection Control Market?
The hospital-acquired infection control market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, solid growth is projected for the hospital-acquired infection control market, with an estimated worth of $44.42 billion in 2029, marking a compound annual growth rate (CAGR) of 5.5%.
This escalation during the forecast period is likely due to the emergence of multidrug-resistant pathogens, preparedness for pandemics, heightened surveillance and monitoring, antimicrobial stewardship programs, and international cooperation. Forecast period trends to watch include the implementation of real-time location systems (RTLS), the use of artificial intelligence (AI) in surveillance, a shift towards utilizing single-use and disposable devices, focusing on staff training and education, and the augmented deployment of disinfection technologies.
Which Key Drivers Are Propelling Th Hospital-Acquired Infection Control Market's Growth?
The escalating cases of COVID-19 are projected to drive the expansion of the hospital-acquired infection control market in the future. The term COVID-19 is given to a viral infection that is produced by the SARS-CoV-2 virus. The pandemic has sparked an increased demand for hospital-acquired infection control products and services, with a renewed focus on personal cleanliness and the manufacturing of infection control medical supplies. For example, data from the World Health Organization, a specialized United Nations agency based in Switzerland, shows that as of 8th August 2022, the number of worldwide COVID-19 cases totaled 581.6 million. As such, the upsurge in COVID-19 cases is fueling the growth of the hospital-acquired infection control market.
What Are The Principal Market Segments In The Global Hospital-Acquired Infection Control Healthcare Industry?
The hospital-acquired infection control market covered in this report is segmented –
1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products
2) By Technology: Phenotypic Methods, Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases
4) By Application: Disease Testing, Drug-Resistance Testing
5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users
Subsegments:
1) By Sterilizers: Steam Sterilizers, Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors, Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors, Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems, Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps, Filters, Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants, Chlorine-based Disinfectants, Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions, Data Management Software
8) By Other Products: Cleaning Equipment, Air Purification Systems
Pre-Book The Hospital-Acquired Infection Control Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Hospital-Acquired Infection Control Market?
Leading corporations in the hospital-acquired infection control market are concentrating their efforts on introducing novel technological solutions, such as an AI system that can detect sepsis in its early stages. This is aimed at improving patient prognosis by ensuring swifter diagnoses and treatment initiation. The sepsis-identifying AI system pertains to pioneering tech tools that use artificial intelligence and machine learning algorithms to recognize the preliminary signs of sepsis in patients. For example, in April 2024, Prenosis Inc., a medical clinic from the US, was given FDA marketing approval for the Sepsis ImmunoScore. This is the first of its kind AI-assisted system intended to forecast sepsis, a potentially fatal condition resulting in severe complications. This cutting-edge device bolsters early detection via real-time data analysis, enabling medical practitioners to act speedily and more efficiently. The inclusion of AI aims to enhance decision-taking support for healthcare staff rather than replacing them, thereby improving patient results and reducing healthcare expenses.
Who Are the Key Players in the Hospital-Acquired Infection Control Market?
Major companies operating in the hospital-acquired infection control market include:
• Johnson and Johnson
• P&G Professional
• Honeywell International Inc.
• MMM Group
• 3M Company
• Becton Dickinson and Company
• Reckitt Benckiser Group plc.
• Ecolab Inc
• Olympus Corporation
• Miele Group
• Biomerieux SA
• Getinge AB
• Halyard Health Inc.
• Ansell Limited
• Sotera Health LLC
• Contec Inc.
• Cantel Medical Corp.
• Belimed AG
• Nanosonics Limited
• Advanced Sterilization Products Services Inc
• Steelco S.P.A
• Schülke & Mayr GmbH
• Metrex Research LLC
• Tristel Solutions Ltd.
• Whiteley Corporation
• PDI Inc.
• Steris Healthcare PVT Ltd
• Matachana Group
• Pal International Ltd.
• Xttrium Laboratories Inc.
• Zep Inc.
What are the Regional Insights into the Hospital-Acquired Infection Control Market?
North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
